Physiology‐Inspired Multilayer Nanofibrous Membranes Modulating Endogenous Stem Cell Recruitment and Osteo‐Differentiation for Staged Bone Regeneration
- 26 August 2022
- journal article
- research article
- Published by Wiley in Advanced Healthcare Materials
- Vol. 11 (21) , 2201457
Abstract
Bone regeneration involves a cascade of sophisticated, multiple‐staged cellular and molecular events, where early‐phase stem cell recruitment mediated by chemokines and late‐phase osteo‐differentiation induced by pro‐osteogenic factors play the crucial roles. Herein, enlightened by a bone physiological and regenerative mechanism, the multilayer nanofibrous membranes (PLLA@SDF‐1α@MT01) consisting of PLLA/MT01 micro‐sol electrospun nanofibers as intima and PLLA/PEG/SDF‐1α electrospun nanofibers as adventitia are fabricated through micro‐sol electrospinning and manual multi‐layer stacking technologies. In vitro releasing profiles show that PLLA@SDF‐1α@MT01 represents the rapid release of stromal cell‐derived SDF‐1α (SDF‐1α) in the outer layers, while with long‐term sustained release of MT01 in the inner layer. Owing to interconnected porosity like the natural bone extracellular matrix and improved hydrophilia, PLLA@SDF‐1α@MT01 manifests good biocompatibility both in vitro and in vivo. Furthermore, PLLA@SDF‐1α@MT01 can promote bone marrow mesenchymal stem cells (BMSCs) migration by amplifying the SDF‐1α/CXCR4 axis and stimulating BMSCs osteo‐differentiation via activating the MAPK pathway in vitro. PLLA@SDF‐1α@MT01, with a programmed dual‐delivery system, exhibits the synergetic promotion of bone regeneration and vascularization by emulating key characteristics of the staged bone repair in vivo. Overall, PLLA@SDF‐1α@MT01 that mimics the endogenous cascades of bone regeneration can enrich the physiology‐mimetic staged regenerative strategy and represent a promising tissue‐engineered scaffold for the bone defect.Keywords
This publication has 56 references indexed in Scilit:
- A Specific Oligodeoxynucleotide Promotes the Differentiation of Osteoblasts via ERK and p38 MAPK PathwaysInternational Journal of Molecular Sciences, 2012
- Repair of Rabbit Osteochondral Defects by an Acellular Technique with an Ultrapurified Alginate Gel Containing Stromal Cell-Derived Factor-1Tissue Engineering Part A, 2012
- Structure-dependent immunostimulatory effect of CpG oligodeoxynucleotides and their delivery systemInternational Journal of Nanomedicine, 2012
- An Oligodeoxynucleotide That Induces Differentiation of Bone Marrow Mesenchymal Stem Cells to Osteoblasts in Vitro and Reduces Alveolar Bone Loss in Rats with PeriodontitisInternational Journal of Molecular Sciences, 2012
- Stromal cell-derived factor-1 enhances distraction osteogenesis-mediated skeletal tissue regeneration through the recruitment of endothelial precursorsBone, 2011
- An Oligodeoxynucleotide with Promising Modulation Activity for the Proliferation and Activation of OsteoblastInternational Journal of Molecular Sciences, 2011
- SDF-1α as a therapeutic stem cell homing factor in myocardial infarctionPharmacology & Therapeutics, 2011
- Stromal derived factor-1 regulates bone morphogenetic protein 2-induced osteogenic differentiation of primary mesenchymal stem cellsThe International Journal of Biochemistry & Cell Biology, 2010
- Delayed administration of adenoviral BMP-2 vector improves the formation of bone in osseous defectsGene Therapy, 2007
- Stromal-derived factor-1 promotes the growth, survival, and development of human bone marrow stromal stem cellsBlood, 2005